BMY:TSX, Bristol-Myers Squibb CDR (CAD Hedged)
BMY stock overview
Bristol-Myers Squibb CDR (CAD Hedged) (BMY:TSX) closed at $23.28 on November 12, 2026,
up 1.04% on the day.
The stock trades 1.3% below its 52-week high of $23.59
and 4.1% above its 52-week low of $22.36.
Over the past year, it gained 2.3%.
Bristol-Myers Squibb CDR (CAD Hedged) is part of the Health Care sector.
Key figures
- Price
- $23.28
- Day change
- +1.04%
- Volume
- 5
- Average volume
- 911
- Market cap
- 181B+
- 52-week range
- $22.36 – $23.59
- 50-day average
- $22.94
- 200-day average
- $22.94
Recent signals
BMY news
-
Nov 14, 2026:
How Many Shares of Pfizer, Merck or Bristol Myers Squibb Pay $1,000 a Month in Dividends?
-
Nov 14, 2026:
3 Defensive Dividend Stocks for Retirees Worried About the Next Market Downturn
-
Nov 14, 2026:
Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story.
-
Nov 13, 2026:
4 Healthcare Dividend Stocks for Retirees. One Yields Over 4%
-
Nov 13, 2026:
What Will Decide Merck Stock Over The Next Six Months?
-
Nov 13, 2026:
2026 NewYorkCISO ORBIE Awards Recognize Greater New York's Top Security Executives
-
Nov 13, 2026:
How to Use the Years Between 62 and 75 to Turn a $1.05 Million IRA Into $5,100 a Month Tax-Free
-
Nov 13, 2026:
A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer
About Bristol-Myers Squibb CDR (CAD Hedged)
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve.
Similar stocks
Find more stocks like BMY with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.